Managing Psoriasis in Women of Childbearing Age
Author Information
Author(s): Yamaguchi Yukie MD, PhD, Spelman Lynda MBBS, FACD, Mizutani Yoko MD, PhD, Lukowski Bartosz PhD, Lanzafame Alfred PhD, Smith Annika MBBS, MPHTM
Primary Institution: Yokohama City University Graduate School of Medicine
Hypothesis
What are the perspectives of women with psoriasis regarding pregnancy and the management of their condition by dermatologists?
Conclusion
Additional safety information can help address concerns about biologic use in women of childbearing age, enabling dermatologists to make informed treatment recommendations.
Supporting Evidence
- Most women with psoriasis felt inadequately informed about pregnancy planning.
- Many dermatologists expressed safety concerns about prescribing TNFi during pregnancy.
- Patients often initiated discussions about pregnancy planning themselves.
Takeaway
Women with psoriasis often feel confused about how their treatment affects pregnancy, and doctors also worry about prescribing certain medications during this time.
Methodology
Online surveys were completed by women aged 18 to 45 years who were pregnant within the past 5 years with moderate to severe psoriasis and dermatologists.
Potential Biases
Potential recall bias among participants and limited demographic representation.
Limitations
Small respondent size, lack of formal validation for questionnaires, recall bias, and generalizability of results.
Participant Demographics
Most participants were aged 31 to 40 years, with a mix of Australian and Japanese respondents.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website